Velcade is a drug from which Bortezomibe is an active ingredient.
This medicine is an injectable antineoplastic agent used to treat tumors such as multiple myeloma.
Its action is to interrupt the equilibrium mechanism of the cell, causing a delay in tumor growth.
Treatment of multiple myeloma
Weakness; Skull pain; insomnia dizziness Anxiety Diarrhea Reduction of hunger constipation; lack of appetite vomiting indigestion decreased blood platelets anemia swelling Low pressure; joint pain pain in the limbs pain in the bones muscle pain back pain difficulty breathing cough, pneumonia skin rash itching; Dehydration Blurred vision.
Risk of pregnancy D; Women who breastfeed; hypersensitivity to the product in children under 18 years of age.
Injectable use
adults
Warning: doses should be given at least 72 hours between them.